CS logo
small CS logo
Synexus Clinical Research US, Inc.

Evansville, Indiana, United States
Doctor in Evansville, Indiana
985C S Kenmore Dr, Evansville, IN 47714

About Synexus Clinical Research US, Inc.


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Synexus Clinical Research US, Inc.


During the past decade, Synexus Clinical Research US, Inc. conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
2015-10-07
2019-08-20
Completed
2,171
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
2017-03-23
2022-07-27
Terminated
10,544
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01
2017-09-29
2020-07-08
Terminated
336
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
2018-02-01
2020-11-05
Terminated
450
A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes
2018-04-05
2019-10-10
Completed
1,842
A Study of Three Different Doses of VAC52416 (ExPEC10V) in Adults Aged 60 to 85 Years in Stable Health
2019-06-06
2024-12-30
Active, not recruiting
836
A Study of an Ad26.RSV.preF-based Regimen in the Prevention of Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)-Confirmed Respiratory Syncytial Virus (RSV)-Mediated Lower Respiratory Tract Disease in Adults Aged 65 Years and Older
2019-08-01
2024-05-16
Active, not recruiting
5,815

Rows per page:

1–7 of 7

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Synexus Clinical Research US, Inc." #1 sponsor was "Allergan" with 2 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored, "Janssen Vaccines & Prevention B.V." with 1 trials sponsored and "Kowa Research Institute, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Synexus Clinical Research US, Inc." #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator and "CoLucid Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsAllergan: 2Allergan: 2Eli Lilly and Company: 2Eli Lilly and Company: 2Janssen Research &Development, LLC: 1Janssen Research &Development, LLC: 1Janssen Vaccines &Prevention B.V.: 1Janssen Vaccines &Prevention B.V.: 1Kowa Research Institute, Inc.: 1Kowa Research Institute, Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsBrigham and Women'sHospital: 1Brigham and Women'sHospital: 1CoLucid Pharmaceuticals: 1CoLucid Pharmaceuticals: 1

Clinical Trials Conditions at Synexus Clinical Research US, Inc.


According to Clinical.Site data, the most researched conditions in "Synexus Clinical Research US, Inc." are "Diabetes Mellitus" (2 trials), "Gastroparesis" (2 trials), "Diabetes Mellitus, Type 2" (1 trials), "Dyslipidemia" (1 trials) and "Extraintestinal Pathogenic Escherichia Coli Prevention" (1 trials). Many other conditions were trialed in "Synexus Clinical Research US, Inc." in a lesser frequency.

Clinical Trials Intervention Types at Synexus Clinical Research US, Inc.


Most popular intervention types in "Synexus Clinical Research US, Inc." are "Drug" (5 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Relamorelin" (2 trials), "Dulaglutide" (1 trials), "ExPEC10V" (1 trials) and "ExPEC4V" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Synexus Clinical Research US, Inc.


The vast majority of trials in "Synexus Clinical Research US, Inc." are 7 trials for "All" genders.

Clinical Trials Status at Synexus Clinical Research US, Inc.


Currently, there are NaN active trials in "Synexus Clinical Research US, Inc.". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Synexus Clinical Research US, Inc., undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Synexus Clinical Research US, Inc., 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 5Phase 3: 5Phase 2: 2Phase 2: 2Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusTerminated: 3Terminated: 3Active, not recruiting: 2Active, not recruiting: 2Completed: 2Completed: 2